Cognition Therapeutics (CGTX) Net Equity Issued and Repurchased (2023 - 2025)
Cognition Therapeutics (CGTX) posted quarterly Net Equity Issued and Repurchased of $800000.0 for Q4 2025, down 86.64% quarter-over-quarter from $6.0 million in Q3 2025.
Cognition Therapeutics (CGTX) Net Equity Issued and Repurchased (2023 - 2025) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $800000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $800000.0; the TTM figure through Dec 2025 stood at $9.1 million (down 23.29% YoY), while the FY2025 annual figure was $9.1 million, down 23.29% from the prior year.
- Net Equity Issued and Repurchased fell to $800000.0 in Q4 2025 per CGTX's latest filing, from $6.0 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $11.9 million in Q1 2024 and bottomed at -$11.5 million in Q2 2024.
- Historically, Net Equity Issued and Repurchased has averaged $1.9 million across 3 years, with a median of $877000.0 in 2025.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 164400.0% in 2024 and fell as far as 599.57% in 2024.
- Cognition Therapeutics' Net Equity Issued and Repurchased stood at -$2.3 million in 2023, then jumped by 599.78% to $11.5 million in 2024, then sank by 93.05% to $800000.0 in 2025.
- Business Quant data shows CGTX's Net Equity Issued and Repurchased at $800000.0 in Q4 2025, $6.0 million in Q3 2025, and $877000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 5.99 Mn |
| Sep 30, 2025 | 5.99 Mn |
| Jun 30, 2025 | 877,000.00 |
| Jun 30, 2025 | 877,000.00 |
| Mar 31, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Sep 30, 2024 | 11.52 Mn |
| Sep 30, 2024 | 11.52 Mn |
| Jun 30, 2024 | -11.52 Mn |
| Jun 30, 2024 | -11.52 Mn |
| Mar 31, 2024 | 11.90 Mn |
| Mar 31, 2024 | 11.90 Mn |
| Dec 31, 2023 | -2.30 Mn |
| Dec 31, 2023 | -2.30 Mn |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 2.31 Mn |
| Jun 30, 2023 | 2.31 Mn |